Col2.3deltaTK
(Plasmid
#114273)
-
PurposeConditional ablation of mature bone cells via ganciclovir exposure of cells expressing a truncated thymidine kinase.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 114273 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBR327
- Backbone size w/o insert (bp) 1850
- Total vector size (bp) 5700
-
Modifications to backboneTet resistance gene deleted.
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCol2.3 promoter + deltaTK + BGH polyA
-
SpeciesR. norvegicus (rat), B. taurus (bovine); Herpes simplex virus
-
Insert Size (bp)3775
- Promoter 2.3 kb rat type 1 collagen
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH1 (not destroyed)
- 3′ cloning site BamH1 (not destroyed)
- 5′ sequencing primer rColprom-121F
- 3′ sequencing primer bGHpA-95R (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDelta TK gene was a gift from Dr. David Klatzmann, Laboratoire de Biologie et The´rapeutique des Pathologies Immunitaires, Centre National de la Recherche Scientifique ERS 107, Hoˆpital de la Pitie´-Salpeˆtrie`re, 75651 Paris Cedex 13, France
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Col2.3deltaTK was a gift from David Rowe (Addgene plasmid # 114273 ; http://n2t.net/addgene:114273 ; RRID:Addgene_114273) -
For your References section:
Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. Visnjic D, Kalajzic I, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, Rowe DW. J Bone Miner Res. 2001 Dec;16(12):2222-31. doi: 10.1359/jbmr.2001.16.12.2222. 10.1359/jbmr.2001.16.12.2222 PubMed 11760835